Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Host innate immune RNA sensors are a specialized class of pattern recognition receptors (PRRs) responsible for detecting non-self or damaged self-RNA molecules within a cell (Chow et al., 2018, Nature Reviews Immunology). These sensors are strategically localized in different cellular compartments: Toll-like receptors (TLR3, TLR7, TLR8) reside in endosomes to monitor extracellular and phagocytosed RNA, while RIG-I-like receptors (RIG-I, MDA5) and other sensors like PKR and OAS1 patrol the cytoplasm (Rehwinkel & Gack, 2020, Nature Reviews Immunology). Upon activation by specific RNA ligands—such as double-stranded RNA or 5-triphosphorylated RNA—these sensors initiate signaling pathways that trigger the production of type I interferons and pro-inflammatory cytokines (Kawai & Akira, 2010, Nature Immunology). This response is critical for establishing an antiviral state and modulating the adaptive immune system. In clinical contexts, dysregulation of these sensors can lead to autoimmune diseases like systemic lupus erythematosus or Aicardi-Goutières syndrome, where the body fails to distinguish self-RNA from viral RNA (Crow, 2014, Nature Reviews Immunology). Consequently, these sensors are major therapeutic targets; agonists are being developed as vaccine adjuvants and cancer immunotherapies to boost immune surveillance, while antagonists are being researched to mitigate chronic inflammatory and autoimmune conditions (Wu & Chen, 2014, Molecular Cell).
Agonism of endosomal or cytosolic receptors to induce type I interferon and pro-inflammatory cytokine production for antiviral or antineoplastic effects; antagonism to suppress pathological inflammation in autoimmune conditions.
7 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Host innate immune RNA sensors (RNA-sensing PRRs).